Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT06017661 |
Other study ID # |
09-AP-ONCON |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 1, 2023 |
Est. completion date |
December 15, 2023 |
Study information
Verified date |
August 2023 |
Source |
AronPharma Sp. z o. o. |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The aim of the study is to demonstrate, under clinical conditions, the effectiveness of the
standard product 'Nutridrink' enriched with a mixture of plant extracts rich in polyphenolic
compounds in the aspect of supporting the recovery of oncology patients undergoing surgical
resection of tumours.
Description:
Oncology patients undergoing the procedure are exposed to various postoperative
complications. Nutridrink with a mixture of extracts with anti-inflammatory and antioxidative
properties aims to provide the patient with essential nutrients and bioactive substances that
can reduce the inflammatory state, protect cells from oxidative damage, and decrease the risk
of complications while supporting tissue healing processes after the surgical procedure. The
study group are oncology patients undergoing surgical resection of gastrointestinal tumour.
During the study, the effects of the mixture on levels of oxidative stress and inflammation
markers will be assessed, as well as the subjective evaluation of patients' quality of life
and well-being after surgical surgical tumor resection.